Development of a risk prediction model for bloodstream infection in patients with fever of unknown origin

被引:3
|
作者
Xu, Teng [1 ,2 ]
Wu, Shi [1 ,2 ]
Li, Jingwen [1 ,2 ]
Wang, Li [1 ,2 ]
Huang, Haihui [1 ,2 ]
机构
[1] Fudan Univ, Huashan Hosp, Inst Antibiot, Shanghai 200040, Peoples R China
[2] Natl Hlth & Family Planning Commiss, Key Lab Clin Pharmacol Antibiot, Shanghai 200040, Peoples R China
基金
中国国家自然科学基金;
关键词
Bloodstream infection; Fever of unknown origin; Serum inflammatory marker; Scoring system; Diagnostic performance; C-REACTIVE PROTEIN; EMERGENCY-DEPARTMENT; ADULT PATIENTS; BACTEREMIA; PROCALCITONIN; ACCURACY;
D O I
10.1186/s12967-022-03796-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background Bloodstream infection (BSI) is a significant cause of mortality among patients with fever of unknown origin (FUO). Inappropriate empiric antimicrobial therapy increases difficulty in BSI diagnosis and treatment. Knowing the risk of BSI at early stage may help improve clinical outcomes and reduce antibiotic overuse. Methods We constructed a multivariate prediction model based on clinical features and serum inflammatory markers using a cohort of FUO patients over a 5-year period by Least Absolute Shrinkage and Selection Operator (LASSO) and logistic regression. ResultsAmong 712 FUO patients, BSI was confirmed in 55 patients. Five independent predictors available within 24 h after admission for BSI were identified: presence of diabetes mellitus, chills, C-reactive protein level of 50-100 mg/L, procalcitonin > 0.3 ng/mL, neutrophil percentage > 75%. A predictive score incorporating these 5 variables has adequate concordance with an area under the curve of 0.85. The model showed low positive predictive value (22.6%), but excellent negative predictive value (97.4%) for predicting the risk of BSI. The risk of BSI reduced to 2.0% in FUO patients if score < 1.5. ConclusionsA simple tool based on 5 variables is useful for timely ruling out the individuals at low risk of BSI in FUO population.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] ROLE OF LYMPHOGRAPHY IN INVESTIGATION OF PATIENTS WITH FEVER OF UNKNOWN ORIGIN
    JONSSON, K
    ACTA MEDICA SCANDINAVICA, 1975, 198 (1-2): : 135 - 136
  • [42] MANAGEMENT OF FEVER OF UNKNOWN ORIGIN IN PATIENTS WITH NEOPLASMS AND NEUTROPENIA
    RODRIGUEZ, V
    BURGESS, M
    BODEY, GP
    CANCER, 1973, 32 (04) : 1007 - 1012
  • [43] Inquiry into the diagnostic workup of patients with fever of unknown origin
    deKleijn, EMHA
    vanderMeer, JWM
    NETHERLANDS JOURNAL OF MEDICINE, 1997, 50 (02): : 69 - 74
  • [44] UTILITY OF SCINTIGRAPHIC METHODS IN PATIENTS WITH FEVER OF UNKNOWN ORIGIN
    DEKLEIJN, EMHA
    OYEN, WJG
    CLAESSENS, RAMJ
    CORSTENS, FHM
    VANDERMEER, JWM
    ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (18) : 1989 - 1994
  • [45] An analysis of etiologies of fever of unknown origin in 372 patients
    石秋萍
    ChinaMedicalAbstracts(InternalMedicine), 2014, 31 (02) : 81 - 82
  • [46] Clinical value of immunoscintigraphy in patients with fever of unknown origin
    Meller, J
    Ivancevic, V
    Conrad, M
    Gratz, S
    Munz, DL
    Becker, W
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (07) : 1248 - 1253
  • [47] Value of FDG PET in patients with fever of unknown origin
    Lorenzen, J
    Buchert, R
    Bohuslavizki, KH
    NUCLEAR MEDICINE COMMUNICATIONS, 2001, 22 (07) : 779 - 783
  • [48] Fever of unknown origin - A time for patience with your patients
    Steele, RW
    CLINICAL PEDIATRICS, 2000, 39 (12) : 719 - 720
  • [49] Fever of unknown origin: evaluation of 30 pediatric patients
    Gundeslioglu, Ozlem Ozgur
    Kocabas, Emine
    Alhan, Emre
    Aksaray, Necmi
    Alabaz, Derya
    Karagun, Barbaros Sahin
    CUKUROVA MEDICAL JOURNAL, 2019, 44 (01): : 215 - 220
  • [50] Overview of fever of unknown origin in adult and paediatric patients
    Attard, L.
    Tadolini, M.
    De Rose, D. U.
    Cattalini, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (01) : S10 - S24